dQ&A research reveals primary care challenges in adopting diabetes tech, highlighting needs for CGM training, simpler tools, and better industry support.
dQ&A is announcing upcoming data releases for our flagship products: Prescriber Perspectives (Europe) and Patient Voice (Europe).
Our latest Diabetes Drug Insights study follows a group of more than n=3,000 people with type 2 diabetes in the USA from 2018 to 2024.
